Stroke is the third leading cause of death in the U.S., and the most common cause of disability. In this talk, I will present new findings from our study exploring CD147 as a novel molecular target for stroke therapy.
Academic Seminars
Guohong Li, Ph.D., Assoc. Prof., Schumpert Medical Center, Endowned Chair in Neurobiology, LSU HSC, Shreveport, LA, will present: “EMMPRIN/CD147: A Novel Molecular Target for Acute Stroke TherapyMarch 4, 2016